Cargando…

NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release

Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) n...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Minghui, Sun, Xuetan, Zhang, Ning, Wang, Wei, Yang, Yang, Jia, Huizhen, Liu, Wenguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051140/
https://www.ncbi.nlm.nih.gov/pubmed/30027047
http://dx.doi.org/10.1002/advs.201800155
_version_ 1783340465026760704
author Li, Minghui
Sun, Xuetan
Zhang, Ning
Wang, Wei
Yang, Yang
Jia, Huizhen
Liu, Wenguang
author_facet Li, Minghui
Sun, Xuetan
Zhang, Ning
Wang, Wei
Yang, Yang
Jia, Huizhen
Liu, Wenguang
author_sort Li, Minghui
collection PubMed
description Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) nanoparticles (DNPs) with a polydopamine film (PDA) that would prolong the blood circulation time of DNPs and avoid the preleakage of the DOX during blood circulation. Meanwhile, the NH(4)HCO(3) is introduced to trigger in situ “bomb‐like” release of DOX for the production of carbon dioxide (CO(2)) and ammonia (NH(3)) gases driven by NIR irradiated photothermal effect of PDA. Both in vitro and in vivo studies demonstrate that the carrier‐free nanovectors with high drug loading efficiency (85.8%) prolong tumor accumulation, enhance chemotherapy, achieve the synergistic treatment of chemotherapy and photothermal treatment, and do not induce any foreign‐body reaction over a three‐week implantation. Hence, the delicate design opens a self‐assembly path to develop PDA‐based NIR‐responsive multifunctional carrier‐free nanoparticles for tumor therapy.
format Online
Article
Text
id pubmed-6051140
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60511402018-07-19 NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release Li, Minghui Sun, Xuetan Zhang, Ning Wang, Wei Yang, Yang Jia, Huizhen Liu, Wenguang Adv Sci (Weinh) Full Papers Carrier‐free nanoparticles with high drug loading have attracted increasing attention; however, in situ on‐demand drug release remains a challenge. Here, a novel near‐infrared (NIR) laser‐induced blasting carrier‐free nanodrug delivery system is designed and fabricated by coating doxorubicin (DOX) nanoparticles (DNPs) with a polydopamine film (PDA) that would prolong the blood circulation time of DNPs and avoid the preleakage of the DOX during blood circulation. Meanwhile, the NH(4)HCO(3) is introduced to trigger in situ “bomb‐like” release of DOX for the production of carbon dioxide (CO(2)) and ammonia (NH(3)) gases driven by NIR irradiated photothermal effect of PDA. Both in vitro and in vivo studies demonstrate that the carrier‐free nanovectors with high drug loading efficiency (85.8%) prolong tumor accumulation, enhance chemotherapy, achieve the synergistic treatment of chemotherapy and photothermal treatment, and do not induce any foreign‐body reaction over a three‐week implantation. Hence, the delicate design opens a self‐assembly path to develop PDA‐based NIR‐responsive multifunctional carrier‐free nanoparticles for tumor therapy. John Wiley and Sons Inc. 2018-05-09 /pmc/articles/PMC6051140/ /pubmed/30027047 http://dx.doi.org/10.1002/advs.201800155 Text en © 2018 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Papers
Li, Minghui
Sun, Xuetan
Zhang, Ning
Wang, Wei
Yang, Yang
Jia, Huizhen
Liu, Wenguang
NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title_full NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title_fullStr NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title_full_unstemmed NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title_short NIR‐Activated Polydopamine‐Coated Carrier‐Free “Nanobomb” for In Situ On‐Demand Drug Release
title_sort nir‐activated polydopamine‐coated carrier‐free “nanobomb” for in situ on‐demand drug release
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051140/
https://www.ncbi.nlm.nih.gov/pubmed/30027047
http://dx.doi.org/10.1002/advs.201800155
work_keys_str_mv AT liminghui niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT sunxuetan niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT zhangning niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT wangwei niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT yangyang niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT jiahuizhen niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease
AT liuwenguang niractivatedpolydopaminecoatedcarrierfreenanobombforinsituondemanddrugrelease